本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fennec Pharmaceuticals Inc.

10.62
-0.1600-1.48%
盤後10.620.00000.00%19:30 EDT
成交量:12.63萬
成交額:134.68萬
市值:3.72億
市盈率:-88.50
高:10.88
開:10.78
低:10.59
收:10.78
52周最高:13.25
52周最低:5.65
股本:3,506.72萬
流通股本:1,988.67萬
量比:0.64
換手率:0.64%
股息:- -
股息率:- -
每股收益(TTM):-0.1200
每股收益(LYR):-0.3409
淨資產收益率:-18.58%
總資產收益率:-1.16%
市淨率:8.77
市盈率(LYR):-31.16

資料載入中...

2024/06/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/25

重要事件披露

Form 8-K - Current report
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/21

重要事件披露

Form 8-K - Current report